Analysts: Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

5,790JPY
10 Jul 2014
Price Change (% chg)

¥-20 (-0.34%)
Prev Close
¥5,810
Open
¥5,830
Day's High
¥5,850
Day's Low
¥5,780
Volume
150,300
Avg. Vol
280,282
52-wk High
¥6,010
52-wk Low
¥4,065

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- March 10 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 1 1
(2) OUTPERFORM 4 3 5 5
(3) HOLD 4 4 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.22 2.30 2.30

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-14 9 144,644.00 149,100.00 139,500.00 --
Year Ending Mar-15 9 160,167.00 171,400.00 154,500.00 140,412.00
Year Ending Mar-16 9 182,011.00 201,100.00 170,900.00 149,257.00
Earnings (per share)
Year Ending Mar-14 10 221.41 242.29 207.24 --
Year Ending Mar-15 10 249.41 289.57 225.20 234.09
Year Ending Mar-16 10 308.61 379.30 248.91 264.60
LT Growth Rate (%) 2 19.55 26.00 13.10 9.80

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 39,854.00 39,717.00 137.00 0.34
Quarter Ending Dec-13 36,850.00 39,683.00 2,833.00 7.69
Quarter Ending Jun-13 32,750.00 34,314.00 1,564.00 4.78
Quarter Ending Sep-12 28,760.00 28,757.00 3.00 0.01
Quarter Ending Jun-12 27,833.30 27,958.00 124.67 0.45

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-14 144,644.00 -- -- -- --
Year Ending Mar-15 160,167.00 160,167.00 161,214.00 152,389.00 140,412.00
Year Ending Mar-16 182,011.00 182,011.00 183,086.00 162,038.00 149,257.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-14 -- -- -- --
Year Ending Mar-15 0 0 0 1
Year Ending Mar-16 0 0 0 1
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks